• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Professional Introduction to 1H-Imidazo[4,5-c]pyridine-4-carboxylic Acid (CAS No. 933728-33-7)

1H-Imidazo[4,5-c]pyridine-4-carboxylic acid, a compound with the chemical identifier CAS No. 933728-33-7, represents a significant area of interest in the field of medicinal chemistry and pharmacology. This heterocyclic compound, featuring a fused imidazole and pyridine ring system, has garnered attention due to its structural versatility and potential biological activities. The carboxylic acid functionality at the 4-position of the imidazo[4,5-c]pyridine core provides a versatile handle for further chemical modifications, making it a valuable scaffold for the development of novel therapeutic agents.

The imidazo[4,5-c]pyridine scaffold is a privileged structure in drug discovery, known for its ability to interact with various biological targets. Recent studies have highlighted the importance of this motif in the design of compounds with anti-inflammatory, antiviral, and anticancer properties. The specific arrangement of nitrogen atoms in the imidazo[4,5-c]pyridine ring system allows for multiple hydrogen bonding interactions, which can be exploited to enhance binding affinity and selectivity towards biological receptors.

In particular, 1H-Imidazo[4,5-c]pyridine-4-carboxylic acid has been explored as a precursor in the synthesis of more complex molecules. The carboxylic acid group at the 4-position serves as a reactive site for esterification, amidation, or coupling reactions, enabling the introduction of diverse substituents that can modulate biological activity. This flexibility has made it a popular choice for medicinal chemists seeking to develop novel inhibitors or agonists targeting specific enzymes or receptors.

Recent advances in computational chemistry have further enhanced the utility of imidazo[4,5-c]pyridine derivatives. Molecular docking studies have identified key interactions between this scaffold and target proteins, providing insights into how structural modifications can optimize binding affinity. These computational approaches have been complemented by experimental validations, where X-ray crystallography has been used to confirm the binding modes of 1H-Imidazo[4,5-c]pyridine-4-carboxylic acid derivatives with their respective targets.

The pharmacological potential of this compound has been demonstrated in several preclinical studies. For instance, derivatives of imidazo[4,5-c]pyridine have shown promise in inhibiting kinases involved in cancer progression. The ability to fine-tune the electronic and steric properties of the molecule has allowed researchers to develop highly selective inhibitors with reduced off-target effects. Additionally, the scaffold has been explored in antiviral contexts, where its capacity to disrupt viral replication cycles has been investigated.

The synthesis of 1H-Imidazo[4,5-c]pyridine-4-carboxylic acid involves multi-step organic transformations that highlight its synthetic accessibility. Common synthetic routes include cyclization reactions followed by functional group modifications to introduce the carboxylic acid moiety. Advances in catalytic methods have also enabled more efficient and sustainable synthetic pathways, reducing waste and improving yields. These developments are crucial for large-scale production and ensure that researchers have access to sufficient quantities of this valuable scaffold.

The versatility of CAS No. 933728-33-7 extends beyond its use as an intermediate in drug development. It has also found applications in materials science and chemical biology, where its unique electronic properties make it useful for designing functional materials or probes for studying biological processes. The ability to incorporate fluorophores or other reporter groups into imidazo[4,5-c]pyridine derivatives has opened up new avenues for imaging and diagnostics.

In conclusion, 1H-imidazo[4,5-c]pyridine-4-carboxylic acid represents a promising compound with significant potential in medicinal chemistry and beyond. Its structural features and reactivity make it an ideal scaffold for developing novel therapeutic agents targeting various diseases. As research continues to uncover new applications and synthetic strategies for this molecule, its importance is likely to grow further.

• 945840-82-4(1H-Pyrrolo[2,3-c]pyridine-7-carboxylic acid)
• 933696-52-7(2-methyl-1H-imidazo[4,5-c]pyridine-4-carboxylic acid)
• 1211590-38-3(3H-Imidazo[4,5-c]pyridine-6-carboxylic acid)
• 26052-96-0(9H-pyrido3,4-bindole-1-carboxylic Acid)
• 138891-64-2(Imidazo[1,5-a]quinoline-3-carboxylic acid)
• 138891-51-7(Imidazo[1,5-A]pyridine-1-carboxylic acid)
• 1234616-18-2(methyl 1H-imidazo[4,5-c]pyridine-4-carboxylate)
• 1078168-26-9(1-methyl-1H-Imidazo[4,5-c]pyridine-4-carboxylic acid)
• 857204-03-6(5H-Pyrrolo[3,2-D]pyrimidine-6-carboxylic acid)
• 1029144-15-7(5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid)